These antibodies are species specific, and the HIRMAb does not recognize the mouse insulin receptor on the tumor vascular endothelium, which originates from mouse brain, and the 8D3 TfRMAb does not recognize the tumor cell human TfR [911,1043]. Here, INSR is linked to neoplasm.